SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

Table of Contents


AveXis, Inc.

Notes to Consolidated Financial Statements (Continued)

12. Stock-based Compensation (Continued)

related to the First Warrant, within research and development expense in the consolidated statements of operations.

          During the year ended December 31, 2014 and the nine months ended September 30, 2015 (unaudited), the total number of stock warrants exercised was 0 and 100,000, respectively, resulting in total proceeds of $0 and $341,000 respectively.

13. Net Loss Per Common Share and Unaudited Pro Forma Net Loss Per Common Share

Net Loss per Common Share

          Basic net loss per common share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed using the sum of the weighted average number of common shares outstanding during the period and, if dilutive, the weighted average number of potential shares of common stock, including the assumed exercise of stock options, stock warrants and unvested restricted common stock. The Company applies the two-class method to calculate its basic and diluted net loss per share attributable to common stockholders, as its preferred stock and common stock are participating securities. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. However, the two-class method does not impact the net loss per share of common stock as the Company was in a net loss position for each of the periods presented and preferred stockholders do not participate in losses. For the years ended December 31, 2013 and 2014 and for the nine months ended September 30, 2014 and 2015, the following potentially dilutive securities have been excluded from the computations of diluted weighted-average shares outstanding because the effect would be anti-dilutive:

 
  Year Ended
December 31,
  Nine Months
Ended
September 30,
 
 
 
2013
 
2014
 
2014
 
2015
 
 
   
   
  (unaudited)
 

Stock options issued and outstanding

        342,900     363,400     1,147,479  

Stock warrants

        293,318     293,318     236,636  

Unvested restricted common stock

        1,268,691     1,268,691     1,268,691  

        1,904,909     1,925,409     2,652,806  

          Amounts in the table above reflect the common stock equivalents of the noted instruments.

F-43



© AveXis, Inc. All Rights Reserved.